Clinical Trials Logo

Pruritus clinical trials

View clinical trials related to Pruritus.

Filter by:

NCT ID: NCT04337073 Completed - Pruritus Clinical Trials

The Effect of Propofol on Dexamethasone-induced Perineal Pruritus

Start date: September 1, 2020
Phase: Early Phase 1
Study type: Interventional

patients may appear serious perineal itching, after injection of dexamethasone sodium phosphate injection its incidence is about 25% ~ 100%, and the incidence of the discomfort in females was much higher than that of the maleTo investigate the effect of propofol pretreatment on perineal pruritus induced by dexamethasone sodium phosphate injection and explore the possible machanisms.

NCT ID: NCT04326738 Completed - Pruritus Clinical Trials

The Effect of Midazolam on Dexamethasone-induced Perineal Pruritus

Start date: January 16, 2020
Phase: Early Phase 1
Study type: Interventional

Dexamethasone is commonly used in clinical practice.However, intravenous dexamethasone sodium phosphate may cause perineal discomfort.With the popularization of comfortable medical technology, patients have higher and higher requirements for comfortable medical treatment.Perineal pruritus caused by intravenous dexamethasone sodium phosphate may cause adverse physiological and psychological effects on patients and increase the incidence of unpleasant experiences during anesthesia.Therefore, it is very important to find a practical and effective method of inhibition.Midazolam is a water-soluble benzodiazepine commonly used in clinical practice, which has been proved to effectively inhibit the itching caused , while its effect on the itching caused by dexamethasone has not been reported.By observing the effect of pre-injection midazolam on the perineal itching caused by dexamethasone sodium phosphate, this experiment intends to preliminarily explore its possible mechanism .

NCT ID: NCT04316533 Completed - Psoriasis Clinical Trials

Work Stress and Impact of Pruritus on Quality of Life

PRUERI
Start date: March 9, 2020
Phase:
Study type: Observational

Work stress and pruritus: imbalance of effort balance reward in patients with psoriasis.

NCT ID: NCT04289038 Completed - Pruritus Clinical Trials

The Efficacy of VR and AR on Pruritus

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

The research will be conducted randomly in order to determine the effect of VR and AR on pruritus symptom.

NCT ID: NCT04099927 Completed - Pruritus Clinical Trials

A Study of SHR4010 in Patients With Hemodialysis

Start date: July 28, 2019
Phase: Phase 1
Study type: Interventional

The study is being conducted to evaluate the safety and pharmacokinetics of SHR0410 in patients with hemodialysis.

NCT ID: NCT04018027 Completed - Atopic Dermatitis Clinical Trials

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis

KARE
Start date: June 29, 2019
Phase: Phase 2
Study type: Interventional

This is a multicenter, randomized, double-blind, 4-arm, placebo-controlled study to evaluate the efficacy and safety of twice-daily (BID) oral difelikefalin (CR845) in adult subjects with atopic dermatitis (AD) and moderate to severe pruritus.

NCT ID: NCT03998163 Completed - Uremic Pruritus Clinical Trials

CR845-CLIN3105: A Study to Evaluate the Safety and Effectiveness of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus

Start date: May 6, 2019
Phase: Phase 3
Study type: Interventional

This is a multicenter, open-label study to evaluate the safety and effectiveness of intravenous (IV) CR845 at a dose of 0.5 mcg/kg administered after each dialysis session. The study includes an up to 12-week Treatment Period.

NCT ID: NCT03997851 Completed - Pruritus Clinical Trials

Topical Acetaminophen for Itch Relief: a Proof of Concept Study in Healthy Subjects

Start date: July 22, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

Currently, topical antihistamines and corticosteroids are mainly used for itching relief. However, the over the counter antihistamines are not effective on all itch conditions. Acetaminophen is a popular and widely used OTC drug for pain relief. Although its mode of action is still unknown, recent studies have shown that acetaminophen indirectly activates cannabinoid CB1 receptors. Recent studies have shown that topical cannabinoid agonists are effective for itch relief, the efficacy of topical acetaminophen will be tested for non-histaminergic itch relief.

NCT ID: NCT03928223 Completed - Pruritus Clinical Trials

The Color of Itch; Itch Modification by Color Viewing

Start date: March 1, 2017
Phase:
Study type: Observational

Itch is the commonest skin-related symptom. There is increasing evidence that itch can be influenced by visual cues. The impact of colors on itch has not yet been studied. This study investigates Itch modification by color viewing and whether patients can match or counteract their itch with a color.

NCT ID: NCT03858634 Completed - Plaque Psoriasis Clinical Trials

A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases

Start date: May 29, 2019
Phase: Phase 2
Study type: Interventional

Participants with diseases characterized by chronic pruritus experiencing moderate to severe pruritus will be enrolled in this pilot Phase 2 study. The diseases characterized by chronic pruritus investigated in this pilot study currently include chronic idiopathic urticaria (CIU), chronic idiopathic pruritus (CIP), lichen planus (LP), lichen simplex chronicus (LSC) and plaque psoriasis (PPs).